Document is current
Any future updates will be listed below
-
Authors
Amstutz, C. https://orcid.org/0000-0003-2755-8138
Behr, J.
Krebs, S.
Haeberlin, A. https://orcid.org/0000-0002-9283-0110
Vogel, R.
Zurbuchen, A. https://orcid.org/0000-0003-0920-378X
Burger, J.
-
Funding
Funding for this research was provided by:
Innosuisse - Schweizerische Agentur für Innovationsförderung (32091.1 IP-LS)
- License Information
-
More Information
Article History
Received: 23 June 2023
Accepted: 15 September 2023
First Online: 23 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: C. Amstutz, J. Burger, and A. Zurbuchen collaborated closely with SIS Medical AG during this investigation. Furthermore, C. Amstutz and J. Burger collaborate closely with Swiss Medical Device AG. Dr. Haeberlin has received travel fees/educational grants from Medtronic, Biotronik, Abbott, and Philips/Spectranetics without impact on his personal remuneration. He serves as a proctor for Medtronic. He is the Co-founder and CEO of Act-Inno AG.
